Literature DB >> 26017536

Proposal of a model for multidisciplinary treatment program of chronic migraine with medication overuse: preliminary study.

L Grazzi1, A Prunesti, G Bussone.   

Abstract

The treatment of patients with chronic migraine associated with medication overuse is challenging in clinical practice; different strategies of treatment have been recently developed, multidisciplinary treatment approaches have been developed in academic headache centers. Education and support of patients are necessary to improve patients' adherence to pharmacological treatments as well as to non-pharmacological therapies. This study reports a clinical experience conducted at our Headache center with a group of female patients, suffering from chronic migraine complicated by medication overuse, treated by a multidisciplinary approach and followed for a period of 1 year after withdrawal. Results confirm the efficacy of a multifaceted treatment to manage this problematic category of patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26017536     DOI: 10.1007/s10072-015-2177-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  The International Classification of Headache Disorders, 3rd edition (beta version).

Authors: 
Journal:  Cephalalgia       Date:  2013-07       Impact factor: 6.292

2.  Multidisciplinary approach to patients with chronic migraine and medication overuse: experience at the Besta Headache Center.

Authors:  L Grazzi
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

Review 3.  Medication overuse and chronic migraine.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2009-10

4.  Meditation for migraines: a pilot randomized controlled trial.

Authors:  Rebecca Erwin Wells; Rebecca Burch; Randall H Paulsen; Peter M Wayne; Timothy T Houle; Elizabeth Loder
Journal:  Headache       Date:  2014-07-18       Impact factor: 5.887

5.  Predictors of outcome of the treatment programme in a multidisciplinary headache centre.

Authors:  Rigmor Jensen; Peter Zeeberg; Christian Dehlendorff; Jes Olesen
Journal:  Cephalalgia       Date:  2010-03-26       Impact factor: 6.292

6.  Headache management program improves outcome for chronic headache.

Authors:  Linda H Harpole; Gregory P Samsa; Annette E Jurgelski; Janice L Shipley; Allan Bernstein; David B Matchar
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

Review 7.  Medication overuse headache.

Authors:  Zaza Katsarava; Dagny Holle; Hans-Christoph Diener
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

8.  The headache management trial: a randomized study of coordinated care.

Authors:  David B Matchar; Linda Harpole; Gregory P Samsa; Annette Jurgelski; Richard B Lipton; Stephen D Silberstein; William Young; Shashidhar Kori; Andrew Blumenfeld
Journal:  Headache       Date:  2008-06-10       Impact factor: 5.887

9.  Treatment of chronic migraine with medication overuse: is drug withdrawal crucial?

Authors:  Licia Grazzi; Frank Andrasik; Susanna Usai; Gennaro Bussone
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

10.  Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study.

Authors:  Charly Gaul; Christina van Doorn; Nadine Webering; Martha Dlugaj; Zaza Katsarava; Hans-Christoph Diener; Günther Fritsche
Journal:  J Headache Pain       Date:  2011-05-05       Impact factor: 7.277

View more
  2 in total

1.  Recruitment, retention, and adherence in a randomized feasibility trial of mindfulness-based stress reduction for patients with migraine.

Authors:  Heather Law; Andrew Avins; Robert Stahl; Michelle Goodreau; Alice Jacobson; Sylvia Sudat; Alice Pressman
Journal:  Complement Ther Med       Date:  2020-11-04       Impact factor: 2.446

2.  The multimodal treatment in headaches.

Authors:  Marco R Lacerenza; Fabia Schoss; Licia Grazzi
Journal:  J Headache Pain       Date:  2015-12       Impact factor: 7.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.